|
We asked 40 pharma leaders, what is your company's most pressing concern?
| Attracting and retaining talent |
44% |
| Pricing and reimbursement issues |
20% |
| Regulatory issues |
20% |
| Pipeline |
16% |
 |
|
|
|
|
|
|
|
|
26 April, 2012 |
 |
| In this Issue |
Inside Greece's Devastated Healthcare System
Greece’s economic crisis has battered the country’s healthcare system, resulting in medicine shortages, market withdrawals and falling profits for the pharma industry. Nathan Jessop reports
Read more... |
Outlook Uncertain for Pharma and Biotech Deals
Peter Young, President and Managing Director of international investment bank Young & Partners, looks at what lies ahead for pharma and biotech deals following a turbulent 2011. More... |
Optimizing CRO Parternships: Looking Beyond the Science
Manuela Leone argues that you should look beyond the science to get the most comprehensive, best-value service from your CRO partner. More... |
Read the Latest Pharm Exec Global Digest Here
This month’s issue, out today, discusses a rare outbreak of harmony in EU pharma circles; what a Scottish vote for independence means for UK pharma; and an interview with India’s most prominent scientist on how to deliver drugs effectively to low income countries. More...
|
| Case Study |
Reducing outsourcing costs and cycle-times
 Discover how a biotech saved $600,000 on a Phase II contract, compressed the contracting cycle-time from three months to two weeks, and formed a more constructive and collaborative working relationship with their CRO.
 Download the case study today.
|
|
|
|
|
|
|
